pf-592,379 pf-592,379 pf-592,379 is a drug developed by pfizer which acts as a potent, selective and orally active agonist for the dopamine d3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erectile dysfunction. unlike some other less selective d3 agonists, a research study showed that pf-592,379 has little abuse potential in animal studies, and so was selected for further development and potentially human clinical trials. development has since been discontinued. pf-592,379clinical dataroutes ofadministrationorallegal statuslegal status investigational (discontinued) identifiers iupac name 5-pyridin-2-amine cas number710655-15-5 ypubchem cid10263487iuphar/bps7683chemspider8438966unii66b7uy5k7ichemical and physical dataformulac13h21n3omolar mass235.331 g·mol−13d model (jsmol)interactive image smiles cccn((c)co1)c1c2=cn=c(n)c=c2 inchi inchi=1s/c13h21n3o/c1-3-6-16-8-12(17-9-10(16)2)11-4-5-13(14)15-7-11/h4-5,7,10,12h,3,6,8-9h2,1-2h3,(h2,14,15)/t10-,12-/m0/s1key:dftcytdjdxzfsk-jqwixifhsa-n